Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2069-2074
Published online before print July 21, 2005, doi: 10.1161/01.ATV.0000178992.40088.f2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/10/2069    most recent
01.ATV.0000178992.40088.f2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, A. M.
Right arrow Articles by McNamara, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, A. M.
Right arrow Articles by McNamara, C. A.
Related Collections
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Animal models of human disease
Right arrow Gene regulation
Right arrow Smooth muscle proliferation and differentiation
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2069.)
© 2005 American Heart Association, Inc.


Vascular Biology

The Effects of Leukocyte-Type 12/15-Lipoxygenase on Id3-Mediated Vascular Smooth Muscle Cell Growth

Angela M. Taylor; Ross Hanchett; Rama Natarajan; Catherine C. Hedrick; Scott Forrest; Jerry L. Nadler; Coleen A. McNamara

From the Cardiovascular Division (A.M.T., C.A.M.), the Cardiovascular Research Center (A.M.T., R.H., C.C.H., S.F., C.A.M.), Department of Molecular Physiology and Biological Physics (C.A.M.), and Department of Endocrinology and Metabolism (C.C.H., J.L.N.), University of Virginia Health Sciences Center, Charlottesville; Gonda Diabetes Center (R.N.), Beckman Research Institute of City of Hope, Duarte, Calif.

Correspondence to Coleen A. McNamara, University of Virginia Health Sciences Center, Cardiovascular Division, PO Box 801394, Charlottesville, VA 22908. E-mail cam8c{at}virginia.edu

Objective— 12/15-Lipoxygenase (12/15-LO) has been implicated in the pathogenesis of vascular disease. Vascular smooth muscle cell (VSMC) proliferation is a key component of the response to injury in vascular disease. The role of 12/15-LO in regulating VSMC proliferation is poorly understood. Id3 has been shown to regulate growth in various cell types and is expressed in VSMCs within atherosclerotic and restenotic lesions. This study examines the role of Id3 in 12/15-LO–mediated VSMC proliferation.

Methods and Results— Primary aortic VSMCs from leukocyte-type 12/15-LO transgenic, leukocyte-type 12/15-LO knockout (KO), and control mice were plated in equal densities and assayed for growth, Id3 protein expression, and Id3 transcription. Results demonstrated that 12/15-LO transgenic VSMCs grew faster, whereas 12/15-LO KO VSMCs grew slower relative to control VSMCs. Further, pharmacological and molecular inhibition of 12/15-LO resulted in decreased VSMC growth. Western blots demonstrated increased Id3 protein in 12/15-LO transgenic VSMCs, whereas luciferase promoter reporter assays revealed increased Id3 transcription. In addition, overexpression of 12/15-LO increased growth in control cells but not in Id3 KO cells. 12/15-LO transgenic VSMCs demonstrated increased protein kinase C (PKC) activity. Consistent with these data, PKC inhibition decreased Id3 promoter activation.

Conclusions— 12/15-LO is an important mediator of VSMC growth. The growth-promoting effects of 12/15-LO are at least partially mediated through induction of Id3 transcription.

12/15-Lipoxygenase (12/15-LO) has been implicated in the pathogenesis of vascular disease. Id3 has been shown to regulate growth in various cell types and is expressed in VSMCs within atherosclerotic and restenotic lesions. The growth-promoting effects of 12/15-LO are at least partially mediated through induction of Id3 transcription.


Key Words: transcription factors • 12/15-lipoxygenase • VSMC • helix-loop-helix factors • restenosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Zhuang, Q. Pu, B. Ceacareanu, Y. Chang, M. Dixit, and A. Hassid
Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H163 - H173.
[Abstract] [Full Text] [PDF]